Nicole L Gonzalez1, Katie M O'Brien, Aimee A D'Aloisio, Dale P Sandler, Clarice R Weinberg. 1. From the aBiostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences, Research triangle Park, NC; bSocial & Scientific Systems, Inc., Durham, NC; and cEpidemiology Branch, National Institute of Environmental Health Sciences, Research triangle Park, NC.
Abstract
BACKGROUND: Douching was recently reported to be associated with elevated levels of urinary metabolites of endocrine disrupting phthalates, but there is no literature on douching in relation to ovarian cancer. Numerous case-control studies of genital talc use have reported an increased risk of ovarian cancer, but prospective cohort studies have not uniformly confirmed this association. Behavioral correlation between talc use and douching could produce confounding. METHODS: The Sister Study (2003-2009) enrolled and followed 50,884 women in the US and Puerto Rico who had a sister diagnosed with breast cancer. At baseline, participants were asked about douching and talc use during the previous 12 months. During follow-up (median of 6.6 years), 154 participants reported a diagnosis of ovarian cancer. We computed adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for ovarian cancer risk using the Cox proportional hazards model. RESULTS: There was little association between baseline perineal talc use and subsequent ovarian cancer (HR: 0.73, CI: 0.44, 1.2). Douching was more common among talc users (odds ratio: 2.1, CI: 2.0, 2.3), and douching at baseline was associated with increased subsequent risk of ovarian cancer (HR: 1.8, CI: 1.2, 2.8). CONCLUSIONS: Douching but not talc use was associated with increased risk of ovarian cancer in the Sister Study.
BACKGROUND: Douching was recently reported to be associated with elevated levels of urinary metabolites of endocrine disrupting phthalates, but there is no literature on douching in relation to ovarian cancer. Numerous case-control studies of genital talc use have reported an increased risk of ovarian cancer, but prospective cohort studies have not uniformly confirmed this association. Behavioral correlation between talc use and douching could produce confounding. METHODS: The Sister Study (2003-2009) enrolled and followed 50,884 women in the US and Puerto Rico who had a sister diagnosed with breast cancer. At baseline, participants were asked about douching and talc use during the previous 12 months. During follow-up (median of 6.6 years), 154 participants reported a diagnosis of ovarian cancer. We computed adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for ovarian cancer risk using the Cox proportional hazards model. RESULTS: There was little association between baseline perineal talc use and subsequent ovarian cancer (HR: 0.73, CI: 0.44, 1.2). Douching was more common among talc users (odds ratio: 2.1, CI: 2.0, 2.3), and douching at baseline was associated with increased subsequent risk of ovarian cancer (HR: 1.8, CI: 1.2, 2.8). CONCLUSIONS: Douching but not talc use was associated with increased risk of ovarian cancer in the Sister Study.
Authors: Karin A Rosenblatt; Noel S Weiss; Kara L Cushing-Haugen; Kristine G Wicklund; Mary Anne Rossing Journal: Cancer Causes Control Date: 2011-03-10 Impact factor: 2.506
Authors: D M Gertig; D J Hunter; D W Cramer; G A Colditz; F E Speizer; W C Willett; S E Hankinson Journal: J Natl Cancer Inst Date: 2000-02-02 Impact factor: 13.506
Authors: Kathryn L Terry; Stalo Karageorgi; Yurii B Shvetsov; Melissa A Merritt; Galina Lurie; Pamela J Thompson; Michael E Carney; Rachel Palmieri Weber; Lucy Akushevich; Wei-Hsuan Lo-Ciganic; Kara Cushing-Haugen; Weiva Sieh; Kirsten Moysich; Jennifer A Doherty; Christina M Nagle; Andrew Berchuck; Celeste L Pearce; Malcolm Pike; Roberta B Ness; Penelope M Webb; Mary Anne Rossing; Joellen Schildkraut; Harvey Risch; Marc T Goodman Journal: Cancer Prev Res (Phila) Date: 2013-06-12
Authors: Katie M O'Brien; Shelley S Tworoger; Holly R Harris; Garnet L Anderson; Clarice R Weinberg; Britton Trabert; Andrew M Kaunitz; Aimee A D'Aloisio; Dale P Sandler; Nicolas Wentzensen Journal: JAMA Date: 2020-01-07 Impact factor: 56.272
Authors: Iwona M Gabriel; Allison F Vitonis; William R Welch; Linda Titus; Daniel W Cramer Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-08-27 Impact factor: 4.254
Authors: Katie M O'Brien; Aimee A D'Aloisio; Min Shi; John D Murphy; Dale P Sandler; Clarice R Weinberg Journal: Epidemiology Date: 2019-11 Impact factor: 4.822
Authors: Christine Tagliaferri Rael; Doyel Das; Jose Bauermeister; Cody Lentz; Alex Carballo-Diéguez; Rebecca Giguere; Rachel K Scott; Craig W Hendrix Journal: AIDS Behav Date: 2021-05-12
Authors: Luigi Vimercati; Domenica Cavone; Maria Celeste Delfino; Biagio Bruni; Luigi De Maria; Antonio Caputi; Stefania Sponselli; Roberta Rossi; Leonardo Resta; Francesco Fortarezza; Federica Pezzuto; Gabriella Serio Journal: Cancers (Basel) Date: 2021-05-10 Impact factor: 6.639
Authors: Mohamed Kadry Taher; Nawal Farhat; Nataliya A Karyakina; Nataliya Shilnikova; Siva Ramoju; Christopher A Gravel; Kannan Krishnan; Donald Mattison; Shi-Wu Wen; Daniel Krewski Journal: Data Brief Date: 2020-02-20
Authors: Alexandra J White; Dale P Sandler; Symielle A Gaston; Chandra L Jackson; Katie M O'Brien Journal: Carcinogenesis Date: 2021-10-05 Impact factor: 4.741